Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Astellas Venture Management
3098
Astellas Venture Management
Suggest edits
Follow us
Also headquartered in Menlo Park
Facebook
Robinhood
Andreessen Horowitz
Sequoia Capital
Kleiner Perkins
Silver Lake
NEA
Lucid Motors
Skydio
Lightspeed Venture Partners
Overview
News
Investments
11
Portfolio
Portfolio Tracker
Add info
Pulse 2.0
Fate Therapeutics Stock Price Increases 37.8%: Why It Happened
$79,500,000
Venture capital (Series B)
PE HUB
Oncorus scores $79.5 mln Series B
Xconomy
At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA
Health
$38,600,000
Venture capital (Series C)
Xconomy
,
vcaonline
Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs
Funding
Health
Science
£4,000,000
Venture capital (Series A)
biospace
,
FinSMEs
Oncorus Announces Additional Series A Financing Support From Astellas Venture Management LLC
Funding
Health
Xconomy
Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug
Health
Science
$37,000,000
Venture capital (Series B)
MedCity News
,
FinSMEs
,
Xconomy
, +1
Startup targeting protein degradation in cancer raises $37M
$43,000,000
Venture capital (Series B)
FinSMEs
Tizona Therapeutics Closes $43M Series B Funding
Health
Funding
Science
$40,000,000
Venture capital (Series B)
The San Diego Union-Tribune
Effector Therapeutics raises $40 million
Science
Health
Funding
Xconomy
Verastem Sinks as Mesothelioma Study Halted For Futility
Health